MENLO PARK, Calif. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design ...

Judge said Abdera didn’t announce the $32.5 million Series A round at the time because the startup did not yet have a story to tell. The cash came before the company had shown its technology can ...

SOUTH SAN FRANCISCO, Calif., January 09, 2025--Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and ...

A precision medicine startup led by biotechnology veterans and backed by B.C.’s AbCellera Biologics Inc. ABCL-Q has raised US$110-million to develop drugs that can deliver radioactive attacks on ...

Abdera skyrockets out of stealth with $142M as radiopharmaceutical ambitions take flight By Max Bayer Apr 20, 2023 6:30am Abdera Therapeutics radiopharmaceuticals Versant Ventures series A ...

SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and ...

The FDA has granted Fast Track Designation to Abdera Therapeutics’ ABD-147, a next-generation precision radiopharmaceutical therapy designed for patients with extensive-stage small cell lung cancer ...

Abdera Therapeutics Inc, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr platform to design and develop tunable and precision radiopharmaceuticals for cancer, announced ...